Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02799537 · ClinicalTrials.gov registry record · NA

Comparing the Stanford Letter Project Form to Traditional Advance Directives

A NA study of Palliative Care and Advance Directives, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT02799537: Recruiting NA study of Palliative Care and Advance Directives, sponsored by Stanford University.

NCT02799537 is a NA study of Palliative Care and Advance Directives that is actively recruiting participants, run by Stanford University. The registered enrollment target is 1,000 participants, below the 1,361-participant average among 18 other Palliative Care trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02799537, a NA study of Palliative Care and Advance Directives, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

Our goal is to compare two types of advance directives forms available in English and Spanish to determine which is more easy to use for patients.

Interventions

  • OTHER Randomized clinical study

Study Locations (1)

California

  • Stanford School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2016-02
Est. Completion 2026-12
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT02799537

The ClinicalTrials.gov registry entry for NCT02799537 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,361-participant average among 18 other Palliative Care trials with a reported enrollment target (27% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Palliative Care appearing as the primary indexed condition, and to 1 intervention - of which Randomized clinical study is the first listed.

NCT02799537 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02799537 about?

NCT02799537 is a clinical study titled "Comparing the Stanford Letter Project Form to Traditional Advance Directives". Our goal is to compare two types of advance directives forms available in English and Spanish to determine which is more easy to use for patients.

What is the current status of trial NCT02799537?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2016-02. Estimated completion is 2026-12.

What conditions does trial NCT02799537 study?

This clinical trial studies the following conditions: Palliative Care, Advance Directives.

What interventions are being tested in trial NCT02799537?

The interventions under investigation include: Randomized clinical study (OTHER).

Who is sponsoring clinical trial NCT02799537?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02799537 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Palliative Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.